Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Lentivirus
100%
Diet-induced Obesity
100%
Gene Delivery
100%
Vasoactive Intestinal Peptide
100%
Type 2 Diabetes Prevention
22%
Gene Expression
11%
Lentiviral Vector
11%
Novel Therapeutics
11%
Therapeutic Approaches
11%
Insulin Resistance
11%
Liver
11%
Glucose Intolerance
11%
Hyperglycemia
11%
Dipeptidyl peptidase-4 (DPP-4)
11%
Pancreatic β-cells
11%
Functional Properties
11%
Intraperitoneal Delivery
11%
Insulin Sensitivity
11%
Experimental Therapeutics
11%
β-cell Dysfunction
11%
Therapeutic Efficacy
11%
Therapeutic Benefits
11%
Peptidase
11%
Glucose Tolerance
11%
Vector Encoding
11%
Peptide Concentration
11%
Anti-inflammatory Properties
11%
Serum Triglycerides
11%
Beta Cell Line
11%
Multiple Injections
11%
Glucose-stimulated Insulin Secretion
11%
Immunocytochemistry
11%
Beneficial Properties
11%
HepG2
11%
Neuropeptide Secretion
11%
Constant Rate Infusion
11%
STZ-induced Diabetes
11%
MIN6 Cells
11%
Insulinotropic Effects
11%
Cholesterol Levels
11%
Immunology and Microbiology
Lentivirus
100%
Human Immunodeficiency Virus
100%
Gene Targeting
100%
Cell Line
50%
Insulin Release
50%
Secretion (Process)
50%
ELISA
50%
Gene Expression
50%
Insulin Sensitivity
50%
Cell Loss
50%
Lentivirus Vector
50%
Cholesterol Level
50%
Triacylglycerol Blood Level
50%
Insulin Resistance
50%
Immunocytochemistry
50%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Vasoactive Intestinal Polypeptide
100%
Diet Induced Obesity
100%
Lentivirus
100%
Gene Delivery
100%
Non Insulin Dependent Diabetes Mellitus
100%
Experimental Therapeutic
11%
Anti-Inflammatory Drug
11%
Enzyme-Linked Immunosorbent Assay
11%
Triacylglycerol
11%
Glucose Intolerance
11%
Streptozotocin-Induced Diabetes Mellitus
11%
Lentivirus Vector
11%
Insulin Resistance
11%
Combination Therapy
11%
Hyperglycemia
11%
Peptidase
11%